$227 Million is the total value of DCF Advisers, LLC's 81 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPFRWS | Exit | JAWS SPITFIRE ACQUISITION CO*w exp 12/01/202 | $0 | – | -30,000 | -100.0% | -0.02% | – |
OBSV | Exit | OBSEVA SA | $0 | – | -26,500 | -100.0% | -0.03% | – |
SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -13,100 | -100.0% | -0.06% | – |
VIAC | Exit | VIACOMCBS INCcall | $0 | – | -5,000 | -100.0% | -0.08% | – |
XLE | Exit | SELECT SECTOR SPDR TRput | $0 | – | -4,500 | -100.0% | -0.09% | – |
MAS | Exit | MASCO CORPcall | $0 | – | -5,000 | -100.0% | -0.10% | – |
TSM | Exit | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $0 | – | -2,500 | -100.0% | -0.11% | – |
LIT | Exit | GLOBAL X FDScall | $0 | – | -4,500 | -100.0% | -0.12% | – |
GMAB | Exit | GENMAB A/Ssponsored ads | $0 | – | -10,000 | -100.0% | -0.14% | – |
NLOK | Exit | NORTONLIFELOCK INC | $0 | – | -15,000 | -100.0% | -0.14% | – |
AYX | Exit | ALTERYX INC | $0 | – | -5,000 | -100.0% | -0.15% | – |
FDX | Exit | FEDEX CORPcall | $0 | – | -1,700 | -100.0% | -0.18% | – |
KWEB | Exit | KRANESHARES TRcsi chi internet | $0 | – | -7,500 | -100.0% | -0.18% | – |
KSS | Exit | KOHLS CORP | $0 | – | -10,000 | -100.0% | -0.20% | – |
IBM | Exit | INTERNATIONAL BUSINESS MACHS | $0 | – | -5,000 | -100.0% | -0.26% | – |
JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -5,000 | -100.0% | -0.29% | – |
MRVL | Exit | MARVELL TECHNOLOGY GROUP LTDord | $0 | – | -17,500 | -100.0% | -0.36% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -6,000 | -100.0% | -0.39% | – |
TSM | Exit | TAIWAN SEMICONDUCTOR MFG LTDput | $0 | – | -10,000 | -100.0% | -0.43% | – |
AAPL | Exit | APPLE INCcall | $0 | – | -9,000 | -100.0% | -0.44% | – |
BMY | Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -25,000 | -100.0% | -0.59% | – |
MU | Exit | MICRON TECHNOLOGY INCput | $0 | – | -20,000 | -100.0% | -0.60% | – |
GLD | Exit | SPDR GOLD TRput | $0 | – | -20,000 | -100.0% | -1.17% | – |
KIN | Exit | KINDRED BIOSCIENCES INC | $0 | – | -362,315 | -100.0% | -1.18% | – |
QQQ | Exit | INVESCO QQQ TRcall | $0 | – | -12,500 | -100.0% | -1.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
ALPHABET INC | 16 | Q3 2023 | 5.8% |
ABBVIE INC | 16 | Q3 2023 | 7.9% |
REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
ARGENX SE | 16 | Q3 2023 | 6.4% |
SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
XENCOR INC | 16 | Q3 2023 | 4.1% |
BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-10 |
13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.